In a significant development in the Indian healthcare sector, PVP Ventures Limited (PVP) announced the acquisition of an initial 41.2% stake in 7Med India Pvt. Ltd. and Epitome Hospitals, with a clearly defined roadmap to achieve majority shareholding within 12 months. This strategic move represents PVP Ventures’ entry into the healthcare services industry, focusing on renal care, nephrology, and urology.

The total investment for the initial stake amounts to approximately INR 127 crore, combining both primary and secondary stake purchases. Subsequent investments will depend on the achievement of specific financial and operational benchmarks outlined in the agreement.

About 7Med India Pvt Ltd and Epitome Hospitals

7Med India Pvt Ltd, headquartered in the Delhi NCR region, is among the top five organized players in India’s renal care sector. The company operates 22 advanced dialysis centres, including shop-in-shop setups within leading hospitals and standalone facilities across six states. Additionally, the group manages four super-specialty hospitals with focused expertise in Nephrology and Urology.

The company is led by a team of highly skilled founders and healthcare specialists, including Dr. Vijay Kher, Dr. Sudhanshu Tyagi, Mr. Ashish Tyagi, Dr. Ajay Kher, Mr. Vikas Verma, Mr. Mayank Sharma, and Dr. Rakesh Thakur. Collectively, the leadership brings decades of experience from organizations such as Fresenius Medical Care, B. Braun Medical, Medanta, and Fortis Group.

For the current financial year, 7Med has reported an EBITDA of approximately INR 10 crore, with projections to reach INR 50 crore over the next four years post-investment. The acquisition is expected to enhance healthcare access in Tier 2 and Tier 3 cities while strengthening the company’s operational and clinical capabilities.

Objectives and Impact of the Acquisition

The primary goal of this acquisition is to build a new-age healthcare platform under PVP Ventures that spans illness management, wellness, and patient care. By bringing 7Med under its fold, PVP aims to:

• Expand dialysis and renal care services across India.

• Improve healthcare infrastructure in Tier 2 and Tier 3 cities.

• Leverage 7Med’s expertise in Nephrology and Urology to provide holistic and world-class care.

• Integrate clinical operations for efficiency, scalability, and affordability.

Mr. Gaurav Davda, Head of M&A and Strategy at PVP Ventures, commented, “This transaction represents a major step in creating a powerful house of brands in healthcare services, focused on Tier 2 and Tier 3 markets. We welcome 7Med and its team and aim to scale it to a national level.”

Dr. Vijay Kher, Shareholder of 7Med and Chairman of Epitome Hospitals, said, “This collaboration combines clinical excellence and innovative healthcare solutions to create a future-ready organization for delivering affordable, high-quality kidney care.”

Structure and Timeline

Under the terms of the agreement:

• PVP Ventures will initially acquire 41.2% stake, with a roadmap to increase ownership to 76% over time.

• The acquisition is structured as a cash consideration for both primary and secondary stakes.

• No governmental or regulatory approvals are required for the transaction.

• The acquisition is expected to be fully executed within 12 months from the date of the announcement.

This structured approach ensures gradual integration while achieving majority control and operational alignment with PVP Ventures’ strategic objectives.

PVP Ventures Limited: Driving Growth

PVP Ventures is focused on building a technology-led house of brands in healthcare services. The company is also monetizing legacy realty assets in collaboration with developers such as Brigade Enterprises Ltd. and Casagrand Premier Builder Ltd., expecting cash flows exceeding INR 2000 crore over the next six years. These resources are being strategically deployed to establish PVP as a leading player in the Indian healthcare sector, creating sustainable value for stakeholders.

Conclusion

The acquisition of 7Med India Pvt Ltd and Epitome Hospitals marks a transformative step for PVP Ventures, enabling the company to expand its footprint in renal care, nephrology, and urology while addressing healthcare gaps in smaller cities. With strong leadership, cutting-edge facilities, and strategic investment, PVP Ventures is poised to emerge as a national leader in integrated healthcare services.

This initiative aligns with the company’s long-term vision of scalable, world-class healthcare solutions and strengthens its commitment to patient-centric services across India.

The Upcoming IPOs in this week and coming weeks are Amanta Healthcare, Rachit Paints, Abril Paper Tech, Sneha Organics, Sugs Lloyd, .

The Current active IPO are Anlon Healthcare, NIS Management, Sattva Engineering Construction, Globtier Infotech, Current Infraprojects, Vikran Engineering, Shivashrit Foods, Anondita Medicare, Classic Electrodes (India).

Start your Stock Market Journey and Apply in IPO by Opening Free Demat Account in Choice Broking FinX.

Join our Trading with CA Abhay Telegram Channel for regular Stock Market Trading and Investment Calls by CA Abhay Varn - SEBI Registered Research Analyst.